GlassScriptPhysician profile
Abdul Rashid
NPI 1821288085
$3,190.76
in general payments reported to CMS, 2019-2025
23 companies · $768 in 2025
The $768 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $14.57 · 2021: $173 · 2022: $272 · 2023: $417 · 2024: $1,402 · 2025: $768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,687 · Travel and Lodging: $812 · Education: $87.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,687.30 |
| Travel and Lodging | $812.13 |
| Education | $87.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,030.67 | 2022-2024 | Watchman Flx |
| Abbott Laboratories | $400.61 | 2022-2025 | Aveir, Jot Dx |
| Merck Sharp & Dohme LLC | $400.47 | 2023-2025 | Verquvo |
| Abiomed | $208.15 | 2019-2021 | |
| Medtronic, INC. | $151.08 | 2021-2023 | Corevalve Evolut R |
| Pfizer INC. | $140.05 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $124.55 | 2023-2025 | Farxiga |
| Kestra Medical Technology Services, INC. | $120.71 | 2024-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.43 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $85.37 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $68.07 | 2024-2025 | Eliquis, Camzyos |
| Scpharmaceuticals INC. | $63.48 | 2024-2025 | |
| Stryker Corporation | $52.13 | 2025 | Flowtriever, Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $43.57 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inspire Medical Systems, INC. | $32.08 | 2025 | Inspire |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $30.65 | 2024 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.19 | 2024 | Jardiance |
| Edwards Lifesciences Corporation | $28.95 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Philips North America LLC | $28.33 | 2020-2024 | (Ck7) Extended Holter |
| Tactile Systems Technology INC | $20.32 | 2025 | Flexitouch Plus, Nimbl |
| Cashflow Solutions, LLC | $17.72 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| G Medical Diagnostic Services, INC. | $14.92 | 2019 | |
| Irhythm Technologies, INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Rashid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.